Pre-Market Fluctuates Ahead of Critical Jobs Report

Key Takeaway

• Pre-market trading shows cautious investor sentiment ahead of jobs data, with S&P 500 futures down 0.05% and Dow Jones futures declining by 0.2%.
• Notable stock movements include DocuSign up 8% after earnings beat, Gap rising 7% on strong Q4 results, while Amylyx Pharmaceuticals plunges 80%, and Marvell Technology drops 5%.

A Mixed Bag Ahead of Jobs Data

As the U.S. stock market braces for the latest jobs data, the pre-market trading session presents a mixed landscape. With S&P 500 futures slightly down by 0.05%, and Nasdaq 100 futures dipping by 0.1%, investors are showing caution. Meanwhile, the Dow Jones Industrial Average futures see a more noticeable decline of 0.2%, contrasting with the MSCI World index's modest gain of 0.1%.

Winners and Losers in the Pre-Market

The pre-market movers are a diverse group, highlighting the varied performance across sectors. In the technology and healthcare sectors, companies like DocuSign and Biogen are making positive strides, with DocuSign's shares up 8% after surpassing fourth-quarter expectations and Biogen gaining 4% following FDA approval for its Alzheimer's treatment. On the other end, Amylyx Pharmaceuticals faces a steep 80% drop after disappointing study results, and Broadcom's shares slip 1.8% due to revenue shortfalls.

Retail and Tech Under the Microscope

Retail and technology sectors are under particular scrutiny this morning. Costco's shares are down 3% after failing to meet revenue and gross margin expectations, while Gap's shares climb 7% on better-than-expected fourth-quarter earnings. In technology, Nvidia continues its impressive rally with a 2.2% increase, whereas Marvell Technology faces a 5% decline after a lukewarm first-quarter forecast.